跳至主要内容
临床试验/CTRI/2021/01/030776
CTRI/2021/01/030776已完成未知

Effectiveness of tibolone in post menopausal depression

Department of psychiatry0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Females who have currently achieved natural menopause
  • Physiologic menopause with amenorrhea for at least 1 year
  • Able to give informed consent
  • First-onset or relapse depression during menopause
  • Patients of depression diagnosed acc to DSM 5 criteria

排除标准

  • 1.Patients with any history of thyroid dysfunction, active or past history of a venous thromboembolic event, breast pathology, undiagnosed vaginal bleeding or abnormal Pap smear results .
  • 2.Patients with any significant unstable medical illness such as epilepsy and diabetes or known active cardiac, renal or liver disease; or the presence of illness causing immobilisation.
  • 3.Patients with psychotic symptoms or past history of severe mental illness.
  • 4.Use of any form of estrogen, progestin or androgen as hormonal therapy, or antiandrogen including Tibolone or use of phytoestrogen supplements as powder or tablet
  • 5.Smoking cigarettes or other nicotine products
  • 6.Illicit drug use
  • 7.More than 3 standard drinks per day

研究者

相似试验